You are here

Drug Forecast

Peginterferon alfa-2a: A New Agent for Hepatitis C Virus Infection

Tarrah Williams, PharmD Candidate, Marlon Honeywell, PharmD, Evans Branch III, PharmD, and Michael Thompson, BCNSP, PharmD
PDF version: 
The authors review peg-interferon alfa-2a (Pegasys®) for the treatment of hepatitis C virus infection.